Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 26, 2025, to stockholders of record at the close of business on March 5, 2025.
Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Joyce J. Lee, MBA, as a Class II director of the Company, effective immediately. Ms. Lee will be an independent director. Her appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent directors.
Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 5, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 6, 2025, at 9:00 AM Eastern Time.
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2024, and its updated financial guidance for the year ending June 30, 2025.
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 18, 2024, to stockholders of record at the close of business on November 27, 2024.
Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the successful completion of the acquisition of the medicated feed additive product portfolio and certain water-soluble products from Zoetis Inc. (
NYSEZTS). This acquisition marks a significant step in furthering Phibro’s purpose to optimize global animal health and nutrition for better lives and a more sustainable world.
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 6, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 7, 2024, at 9:00 AM Eastern Time.
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference.
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2024 and provided its financial guidance for the year ending June 30, 2025.
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2024 financial results on Wednesday, August 28, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 29, 2024, at 9:00 AM Eastern Time.
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 25, 2024, to stockholders of record at the close of business on September 4, 2024.
Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability
Phibro Animal Health Corporation (Nasdaq: PAHC) proudly announces its third annual Environmental, Social and Governance (ESG) Report, highlighting 2023 achievements. At Phibro, the connections between people, animals and the planet drive us to optimize animal health and nutrition for better lives and a sustainable world.
Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Annual Dental and Animal Health (Jaws & Paws) Conference.
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2024, and its updated financial guidance for the year ending June 30, 2024.
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 26, 2024, to stockholders of record at the close of business on June 5, 2024.
Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health
Zoetis Inc. (
NYSEZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 8, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 9, 2024, at 9:00 AM Eastern Time.
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Global Healthcare Conference.
Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2024 Virtual Animal Health Summit.
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2023 and its updated financial guidance for the year ending June 30, 2024.
Phibro Animal Health Corporation Declares Quarterly Dividend
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 27, 2024, to stockholders of record at the close of business on March 6, 2024.
Phibro Animal Health Corporation Announces Chief Financial Officer Changes
Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024. Mr. Richard Johnson, who is currently serving as Phibro’s interim Chief Financial Officer since September 29, 2023, will continue with Phibro for a period of time in an advisory capacity to ensure a smooth transition with his successor.
Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 7, 2024, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 8, 2024, at 9:00 AM Eastern Time.
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2023, and its updated financial guidance for the year ending June 30, 2024.
Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers
(
NASDAQPAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions regarding Mecadox® (carbadox), a drug marketed by Phibro Animal Health Corporation.
